What rhymes with catalystpharma?
cat·a·lyst·phar·ma

Catalyst is a specialty pharmaceutical company focused on the development and commercialization of prescription drugs targeting rare (orphan) neuromuscular and neurological diseases, including Lambert-Eaton Myasthenic Syndrome (LEMS), infantile spasms and Tourette’s disorder. Catalyst is developing Firdapse™ (Amifampridine Phosphate, or 3,4-diaminopyridine phosphate) for the treatment of LEMS, a rare neuromuscular, autoimmune disorder frequently associated with small cell lung cancer. Catalyst also believes that Firdapse™ has the potential to treat other neuromuscular disorders such as congenital myasthenic syndrome and some cases of myasthenia gravis that are refractory to currently approved therapies.Catalyst is also developing a highly potent GABA-aminotransferase (GABA-AT) inhibitor, designated CPP-115, for the treatment of infantile spasms, a rare form of debilitating epileptic seizures that presents in infants. In in-vitro studies, CPP-115 has proven 200 times more potent than vigabatrin and pre-clinical data suggest that it may also have a better side effect profile. Catalyst licensed rights to CPP-115 and other novel GABA-AT inhibitors discovered by researchers at Northwestern University.In addition to infantile spasms, CPP-115 may prove effective for a wide range of indications, such as other forms of epilepsy, and perhaps central nervous system (CNS) conditions that result from hypoGABAergic signaling defects, such as Tourette’s disorder, post-traumatic stress disorder, and movement disorders. Catalyst believes that it controls all current intellectual property for GABA-aminotransferase inhibitors.

more definitions for catalystpharma »